FDA Approves First Gene Therapy to Treat Adults with Metastatic Synovial Sarcoma
For Immediate Release: August 02, 2024 The U.S. Food and Drug Administration approved Tecelra (afamitresgene autoleucel), a gene therapy indicated for the treatment of adults with unresectable or metastatic synovial sarcoma who have received prior …